RelB, together with RelA, sustains cell survival and confers proteasome inhibitor sensitivity of chronic lymphocytic leukemia cells from bone marrow (Q42444933)

From Wikidata

Jump to navigation Jump to search

scientific article published on 17 September 2013

Language	Label	Description	Also known as
English	RelB, together with RelA, sustains cell survival and confers proteasome inhibitor sensitivity of chronic lymphocytic leukemia cells from bone marrow	scientific article published on 17 September 2013

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

RelB, together with RelA, sustains cell survival and confers proteasome inhibitor sensitivity of chronic lymphocytic leukemia cells from bone marrow (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

1 reference

based on heuristic

inferred from title

chronic lymphocytic leukemia

1 reference

based on heuristic

inferred from title

author name string

Jingjing Xu

1

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

Peng Zhou

2

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

Wenjuan Wang

3

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

Aining Sun

4

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

Feng Guo

5

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

publication date

17 September 2013

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

Journal of Molecular Medicine

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

92

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

77-92

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

Molecular pathogenesis of chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1081-6

21 January 2018

Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1081-6

21 January 2018

Disruption of BIRC3 associates with fludarabine chemorefractoriness in TP53 wild-type chronic lymphocytic leukemia.

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1081-6

21 January 2018

A sustained activation of PI3K/NF-kappaB pathway is critical for the survival of chronic lymphocytic leukemia B cells.

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1081-6

21 January 2018

NF-kappaB as a therapeutic target in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1081-6

21 January 2018

Regulation and function of NF-kappaB transcription factors in the immune system

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1081-6

21 January 2018

NF-κB and the link between inflammation and cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1081-6

21 January 2018

Regulation of secondary lymphoid organ development by the nuclear factor-kappaB signal transduction pathway

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1081-6

21 January 2018

The NF-kappaB subunit Rel A is associated with in vitro survival and clinical disease progression in chronic lymphocytic leukemia and represents a promising therapeutic target

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1081-6

21 January 2018

Rel a is an independent biomarker of clinical outcome in chronic lymphocytic leukemia.

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1081-6

21 January 2018

Classical and/or alternative NF-kappaB pathway activation in multiple myeloma

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1081-6

21 January 2018

RelB-dependent stromal cells promote T-cell leukemogenesis

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1081-6

21 January 2018

TRAF1 is involved in the classical NF-kappaB activation and CD30-induced alternative activity in Hodgkin's lymphoma cells

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1081-6

21 January 2018

Hodgkin lymphoma requires stabilized NIK and constitutive RelB expression for survival

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1081-6

21 January 2018

Maspin expression is regulated by the non-canonical NF-κB subunit in androgen-insensitive prostate cancer cell lines

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1081-6

21 January 2018

RelB is required for Peyer's patch development: differential regulation of p52-RelB by lymphotoxin and TNF

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1081-6

21 January 2018

In vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cells

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1081-6

21 January 2018

Nurture versus nature: the microenvironment in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1081-6

21 January 2018

The lymph node microenvironment promotes B-cell receptor signaling, NF-κB activation, and tumor proliferation in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1081-6

21 January 2018

Prognostic markers and stratification of chronic lymphocytic leukemia.

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1081-6

21 January 2018

RelB enhances prostate cancer growth: implications for the role of the nuclear factor-kappaB alternative pathway in tumorigenicity

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1081-6

21 January 2018

RelB regulates manganese superoxide dismutase gene and resistance to ionizing radiation of prostate cancer cells

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1081-6

21 January 2018

Oestrogen signalling inhibits invasive phenotype by repressing RelB and its target BCL2.

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1081-6

21 January 2018

RelB NF-kappaB represses estrogen receptor alpha expression via induction of the zinc finger protein Blimp1.

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1081-6

21 January 2018

Inhibition of RelB by 1,25-dihydroxyvitamin D3 promotes sensitivity of breast cancer cells to radiation

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1081-6

21 January 2018

BAFF and APRIL support chronic lymphocytic leukemia B-cell survival through activation of the canonical NF-kappaB pathway

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1081-6

21 January 2018

Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1081-6

21 January 2018

Diverse marrow stromal cells protect CLL cells from spontaneous and drug-induced apoptosis: development of a reliable and reproducible system to assess stromal cell adhesion-mediated drug resistance

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1081-6

21 January 2018

Bone marrow stromal cells prevent apoptosis of lymphoma cells by upregulation of anti-apoptotic proteins associated with activation of NF-kappaB (RelB/p52) in non-Hodgkin's lymphoma cells

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1081-6

21 January 2018

Bi-directional activation between mesenchymal stem cells and CLL B-cells: implication for CLL disease progression

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1081-6

21 January 2018

Stromal endothelial cells establish a bidirectional crosstalk with chronic lymphocytic leukemia cells through the TNF-related factors BAFF, APRIL, and CD40L.

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1081-6

21 January 2018

BCL-2 phosphorylation modulates sensitivity to the BH3 mimetic GX15-070 (Obatoclax) and reduces its synergistic interaction with bortezomib in chronic lymphocytic leukemia cells.

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1081-6

21 January 2018

Phase II study of single-agent bortezomib for the treatment of patients with fludarabine-refractory B-cell chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1081-6

21 January 2018

TNF receptor (TNFR)-associated factor (TRAF) 3 serves as an inhibitor of TRAF2/5-mediated activation of the noncanonical NF-kappaB pathway by TRAF-binding TNFRs

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1081-6

21 January 2018

AT-101 induces apoptosis in CLL B cells and overcomes stromal cell-mediated Mcl-1 induction and drug resistance

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1081-6

21 January 2018

The role of chemokines in B cell chronic lymphocytic leukaemia: pathophysiological aspects and clinical impact

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1081-6

21 January 2018

Bone biopsy derived marrow stromal elements rescue chronic lymphocytic leukemia B-cells from spontaneous and drug induced cell death and facilitates an "angiogenic switch".

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1081-6

21 January 2018

Constitutive alternative NF-kappaB signaling promotes marginal zone B-cell development but disrupts the marginal sinus and induces HEV-like structures in the spleen.

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1081-6

21 January 2018

Cellular origin(s) of chronic lymphocytic leukemia: cautionary notes and additional considerations and possibilities

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1081-6

21 January 2018

Triggering of CD40 antigen inhibits fludarabine-induced apoptosis in B chronic lymphocytic leukemia cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24042463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

From pathogenesis to treatment of chronic lymphocytic leukaemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/24042463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human bone marrow stromal cells prevent apoptosis and support the survival of chronic lymphocytic leukaemia cells in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/24042463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

IGHV unmutated CLL B cells are more prone to spontaneous apoptosis and subject to environmental prosurvival signals than mutated CLL B cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/24042463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

NOTCH1 mutations identify a genetic subgroup of chronic lymphocytic leukemia patients with high risk of transformation and poor outcome.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24042463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacological inhibitors of NF-κB accelerate apoptosis in chronic lymphocytic leukaemia cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/24042463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lack of nuclear factor-kappa B2/p100 causes a RelB-dependent block in early B lymphopoiesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/24042463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

TRAF3 in B cells: too much, too little, too bad

1 reference

https://pubmed.ncbi.nlm.nih.gov/24042463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Downregulation of BCL2 by AT-101 enhances the antileukaemic effect of lenalidomide both by an immune dependant and independent manner

1 reference

https://pubmed.ncbi.nlm.nih.gov/24042463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chronic lymphocytic leukemia B cells express functional CXCR4 chemokine receptors that mediate spontaneous migration beneath bone marrow stromal cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24042463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Distinct gene expression profiling in chronic lymphocytic leukemia with 11q23 deletion

1 reference

https://pubmed.ncbi.nlm.nih.gov/24042463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chronic lymphocytic leukemic B cells but not normal B cells are rescued from apoptosis by contact with normal bone marrow stromal cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/24042463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gene mutation revelation points to new target for myeloma treatment, studies say

1 reference

https://pubmed.ncbi.nlm.nih.gov/24042463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Modulation of NF-kappa B activity and apoptosis in chronic lymphocytic leukemia B cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/24042463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00109-013-1081-6

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42444933&oldid=2205390766"